A retrospective study of urokinase-type plasminogen activator receptor (uPAR) as a prognostic factor in cancer of the uterine cervix.
Sasaki, Toru; Nishi, Hirotaka; Nagata, Chie; Nagai, Takeshi; Nagao, Toshitaka; Terauchi, Fumitoshi; Isaka, Keiichi.
Int J Clin Oncol
; 19(6): 1059-64, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24474395
Genomic characterization of cervical cancer based on human papillomavirus status.
State of the science in cervical cancer: where we are today and where we need to go.
Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer.
High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
Surgical treatment of stage IA2 cervical cancer.
Extended-field radiotherapy for locally advanced cervical cancer.
FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.
Association of MBL2 exon1 polymorphisms with high-risk human papillomavirus infection and cervical cancers: a meta-analysis.
Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls.
LncRNAs: key players and novel insights into cervical cancer.